Abstract
Chronic infection with the hepatitis B virus (HBV) affects an estimated 257 million people worldwide and can lead to liver diseases such as cirrhosis and liver cancer. Viral replication is generally considered not to be cytopathic, and although some HBV proteins may have direct carcinogenic effects, the majority of HBV infection-related disease is related to chronic inflammation resulting from disrupted antiviral responses and aberrant innate immune reactions. Like all cells, healthy and HBV-infected cells communicate with each other, as well as with other cell types, such as innate and adaptive immune cells. They do so by both interacting directly and by secreting factors into their environment. Such factors may be small molecules, such as metabolites, single viral proteins or host proteins, but can also be more complex, such as virions, protein complexes, and extracellular vesicles. The latter are small, membrane-enclosed vesicles that are exchanged between cells, and have recently gained a lot of attention for their potential to mediate complex communication and their potential for therapeutic repurposing. Here, we review how HBV infection affects the communication between HBV-infected cells and cells in their environment. We discuss the impact of these interactions on viral persistence in chronic infection, as well as their relation to HBV infection-related pathology.
Funder
Deutsche Forschungsgemeinschaft
German Center for Infection research
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference142 articles.
1. World Health Organization (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, Accountability for the Global Health Sector Strategies 2016–2021: Actions for Impact.
2. Innate and adaptive immune responses in chronic hepatitis B virus infections: Towards restoration of immune control of viral infection;Bertoletti;Gut,2012
3. Immune responses and immunopathology in acute and chronic viral hepatitis;Shin;Nat. Rev. Immunol.,2016
4. Rubido, J.C.A., Klundert, M.A.A., and Michel, M.L. (2017). Chronic Hepatitis B Treatment: Statu Quo and New Developments, Semantical Scholar. Chapter 2 Hepatitis: A Global Health Concern.
5. Prevention of mother-to-child transmission of hepatitis B: Birth-dose vaccination is not enough;Noubiap;Lancet. Glob. Health,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献